Status and phase
Conditions
Treatments
About
Study clinical multicenter, phase III, open-label, prospective character to evaluate the efficacy and safety Susanna Implant in patients with refractory glaucoma.
Full description
Clinical trial multicenter, phase III,open-label, prospective character to evaluate the efficacy and safety of Susanna Implant in patients with refractory glaucoma of both genders, of any race, aged above 18 years and diagnosed with glaucoma refractory.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Neovascular glaucoma group:
Group post-trabeculectomy failure:
Exclusion criteria
Group post-trabeculectomy failure:
Neovascular glaucoma group:
Primary purpose
Allocation
Interventional model
Masking
76 participants in 1 patient group
Loading...
Central trial contact
Fernanda Lima, Coordinator; Augusto Paranhos, Investigator
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal